{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:46:13Z","timestamp":1791895573306,"version":"4.3.4"},"reference-count":30,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej19-0036","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T22:02:53Z","timestamp":1560290573000},"page":"881-889","source":"Crossref","is-referenced-by-count":16,"title":["Clinical outcomes of parathyroidectomy &lt;i&gt;versus&lt;\/i&gt; cinacalcet in the clinical management of secondary hyperparathyroidism"],"prefix":"10.1507","volume":"66","author":[{"given":"Won Woong","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Seok","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho Rok","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Wook","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jandee","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Ju","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee-Hyun","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woong Youn","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Mei C, Chen N, Ding X, Yu X, Wang L, et al. (2016) Efficacy and safety of cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis. Hemodial Int 20: 589\u2013600.","DOI":"10.1111\/hdi.12410"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Tominaga Y, Matsuoka S, Uno N, Sato T (2008) Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 12 Suppl 1: S21\u2013S26.","DOI":"10.1111\/j.1744-9987.2008.00627.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Friedl C, Reibnegger G, Kramar R, Zitt E, Pilz S, et al. (2017) Mortality in dialysis patients with cinacalcet use: a large observational registry study. Eur J Intern Med 42: 89\u201395.","DOI":"10.1016\/j.ejim.2017.05.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Akizawa T, Kurita N, Mizobuchi M, Fukagawa M, Onishi Y, et al. (2016) PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Sci Rep 6: 19612.","DOI":"10.1038\/srep19612"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Bergua C, Torregrosa JV, Fuster D, Gutierrez-Dalmau A, Oppenheimer F, et al. (2008) Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation 86: 413\u2013417.","DOI":"10.1097\/TP.0b013e31817c13e1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Evenepoel P (2008) Calcimimetics in chronic kidney disease: evidence, opportunities and challenges. Kidney Int 74: 265\u2013275.","DOI":"10.1038\/ki.2008.166"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Strippoli GF, Palmer S, Tong A, Elder G, Messa P, et al. (2006) Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. Am J Kidney Dis 47: 715\u2013726.","DOI":"10.1053\/j.ajkd.2006.01.015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-Dechent W, et al. (2017) Blood calcification propensity, cardiovascular events, and survival in patients receiving hemodialysis in the EVOLVE trial. Clin J Am Soc Nephrol 12: 315\u2013322.","DOI":"10.2215\/CJN.04720416"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Bellasi A, Cozzolino M, Russo D, Molony D, Di Iorio B (2016) Cinacalcet but not vitamin D use modulates the survival benefit associated with sevelamer in the INDEPENDENT study. Clin Nephrol 86: 113\u2013124.","DOI":"10.5414\/CN108827"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drueke TB, et al. (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367: 2482\u20132494.","DOI":"10.1056\/NEJMoa1205624"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Trombetti A, Stoermann C, Robert JH, Herrmann FR, Pennisi P, et al. (2007) Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism. World J Surg 31: 1014\u20131021.","DOI":"10.1007\/s00268-006-0693-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Conzo G, Perna AF, Savica V, Palazzo A, Della Pietra C, et al. (2013) Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era. BMC Surg 13 Suppl 2: S4.","DOI":"10.1186\/1471-2482-13-S2-S4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Dussol B, Morand P, Martinat C, Lombard E, Portugal H, et al. (2007) Influence of parathyroidectomy on mortality in hemodialysis patients: a prospective observational study. Ren Fail 29: 579\u2013586.","DOI":"10.1080\/08860220701392447"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Tominaga Y, Matsuoka S, Uno N (2009) Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis. World J Surg 33: 2335\u20132342.","DOI":"10.1007\/s00268-009-9943-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kim GH, Choi BS, Cha DR, Chee DH, Hwang E, et al. (2014) Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: a multicentre study in Korea. Kidney Res Clin Pract 33: 52\u201357.","DOI":"10.1016\/j.krcp.2013.12.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kim WY, Lee JB, Kim HY, Woo SU, Son GS, et al. (2013) Achievement of the national kidney foundation kidney disease outcomes quality initiative: recommended serum calcium, phosphate and parathyroid hormone values with parathyroidectomy in patients with secondary hyperparathyroidism. J Korean Surg Soc 85: 25\u201329.","DOI":"10.4174\/jkss.2013.85.1.25"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 van der Plas WY, Dulfer RR, Engelsman AF, Vogt L, de Borst MH, et al. (2017) Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review. Nephrol Dial Transplant 32: 1902\u20131908.","DOI":"10.1093\/ndt\/gfx044"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Shaheen FA, Kurpad R, Al-Sayyari AA, Souqiyyeh MZ, Aljubori H, et al. (2016) Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: the OCEANOS study. Saudi J Kidney Dis Transpl 27: 290\u2013304.","DOI":"10.4103\/1319-2442.178266"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, et al. (2015) Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int 87: 846\u2013856.","DOI":"10.1038\/ki.2014.349"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Hwang E, Choi BS, Oh KH, Kwon YJ, Kim GH (2015) Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations. Kidney Res Clin Pract 34: 4\u201312.","DOI":"10.1016\/j.krcp.2015.02.002"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, et al. (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305: 1119\u20131127.","DOI":"10.1001\/jama.2011.308"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Rivara MB, Ravel V, Kalantar-Zadeh K, Streja E, Lau WL, et al. (2015) Uncorrected and albumin-corrected calcium, phosphorus, and mortality in patients undergoing maintenance dialysis. J Am Soc Nephrol 26: 1671\u20131681.","DOI":"10.1681\/ASN.2014050472"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Lee YT, Ng HY, Chiu TT, Li LC, Pei SN, et al. (2016) Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients. Clin Chim Acta 452: 38\u201343.","DOI":"10.1016\/j.cca.2015.10.031"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, et al. (2015) Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation 132: 27\u201339.","DOI":"10.1161\/CIRCULATIONAHA.114.013876"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Block G, Port FK (2003) Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial 16: 140\u2013147.","DOI":"10.1046\/j.1525-139X.2003.160301.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Moshar S, Bayesh S, Mohsenikia M, Najibpour R (2016) The association of calcium-phosphorus product with the severity of cardiac valves failure in patients under chronic hemodialysis. Cardiol Res 7: 80\u201383.","DOI":"10.14740\/cr465w"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, et al. (2001) More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 38: S168\u2013S171.","DOI":"10.1053\/ajkd.2001.27432"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Narayan R, Perkins RM, Berbano EP, Yuan CM, Neff RT, et al. (2007) Parathyroidectomy <i>versus<\/i> cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 49: 801\u2013813.","DOI":"10.1053\/j.ajkd.2007.03.009"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Celtik A, Sen S, Yilmaz M, Demirci MS, Asci G, et al. (2016) The effect of hypercalcemia on allograft calcification after kidney transplantation. Int Urol Nephrol 48: 1919\u20131925.","DOI":"10.1007\/s11255-016-1391-z"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Kestenbaum B, Andress DL, Schwartz SM, Gillen DL, Seliger SL, et al. (2004) Survival following parathyroidectomy among United States dialysis patients. Kidney Int 66: 2010\u20132016.","DOI":"10.1111\/j.1523-1755.2004.00972.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/10\/66_EJ19-0036\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T03:42:39Z","timestamp":1572666159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/10\/66_EJ19-0036\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0036","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}